Zusammenfassung
Die Identifizierung angiogener Wachstumsfaktoren ermöglichte die Entwicklung neuartiger Strategien zur Behandlung chronischer Gefäßverschlüsse. Die therapeutische Angiogenese könnte eine potentielle alternative Therapie für Patienten mit einer kritischen Beinischämie auf dem Boden einer Kapillaraussprossung (Angiogenese) und der Neubildung von Kollateralgefäßen (Arteriogenese) darstellen. In-vitro-und experimentelle In-vivo-Untersuchungen konnten die Wirksamkeit der vermehrten Kollateralenbildung und funktionellen Durchblutungsverbesserung bei experimenteller Beinischämie sowohl für rekombinante Gefäßwachstumsfaktoren als auch für gentherapeutische Strategien nachweisen. Gentherapeutische Strategien besitzen den Vorteil einer Minimierung systemischer Nebenwirkungen und der langsamen und kontinuierlichen Freisetzung des kodierten Faktors, was einen länger anhaltenden angiogenen Effekt er-laubt. In überwiegend unkontrollierten klinischen-Phase-I- und -IIa-Studien wurden die Machbarkeit und die Effizienz der Gefäßbehandlungen mit Wachstumsfaktoren gezeigt. Die Ergebnisse plazebokontrollierter, und doppelblinder Studien sind zur sicheren Beurteilung des therapeutischen Pozentials abzuwarten.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM (1995) Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92:I365–371
Asahara T, Chen D, Tsurumi Y, Kearney M, Rossow S, Passeri J, Symes JF, Isner JM (1996) Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation 94:3291–3302
Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221–228
Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P (1992) Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 16:181–191
Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, Isner JM (1998) Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia [see comments]. Circulation 97:1114–1123
Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM (1994) Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am J Physiol 267:H1263–1271
Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, Isner JM (1996) Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 97:469–476
Bush RL, Pevec WC, Ndoye A, Cheung AT, Sasses J, Pearson DN (1998) Regulation of new blood vessel growth into ischemic skeletal muscle. J Vasc Surg 28:919–928
Chleboun JO, Martins RN, Mitchell CA, Chirila TV (1992) bFGF enhances the development of the collateral circulation after acute arterial occlusion. Biochem Biophys Res Commun 185:510–516
Ferrara N, Alitalo K (1999) Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 5:1359–1364
Folkman J (1971) Tumor angiogenesis: Therapeutic implications. N Engl J Med 285:1182–1186
Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27–31
Goede V, Brogelli L, Ziche M, Augustin HG (1999) Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer 82: 765–770
Harada K, Friedman M, Lopez JJ, Wang SY, Li J, Prasad PV, Pearlman JD, Edelman ER, Selike FW, Simons M (1996) Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol 270:H1791–1802
Ibukiyama C (1996) Angiogenic therapy using fibroblast growth factors and vascular endothelial growth factors for ischemic vascular lesions. Jpn Heart J 37:285–300
Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, Doi K, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Chun TH, Masatsugu K, Becker AE, Nakao K (1998) Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysio-logical significance of VEGF in progression of atherosclerosis. Circulation 98:2108–2116
Ischemia EWGocl (1991) Second European Con-sensus document on chronic critical leg ischemia. Circulation 84(Suppl IV):IV1–IV26
Isner JM, Asahara T (1999) Angiogenesis and vas-culogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 103:1231–1236
Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, Symes JF (1996) Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb [see comments]. Lancet 348:370–374
Isner JM, Walsh K, Symes J, Pieczek A, Takeshita S, Lowry J, Rosenfield K, Weir L, Brogi E, Jurayj D (1996) Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum Gene Ther 7:959–988
Isner JM, Baumgartner I, Rauh G, Schainfeld R, Blair R, Manor O, Razvi S, Symes JF (1998) Treat-ment of thromboangiitis obliterans (Buerger’s disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg 28:964–973
Ito WD, Arras M, Scholz D, Winkler B, Htun P, Schaper W (1997) Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol 273: H1255–1265
Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W (1997) Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 80:829–837
Laitinen M, Makinen K, Manninen H, Matsi P, Kossila M, Agrawal RS, Pakkanen T, Luoma JS, Viita H, Hartikainen J, Alhava E, Laakso M, Ylä-Herttuala S (1998) Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther 9:1481–1486
Lazarous DF, Scheinowitz M, Shou M, Hodge E, Rajanayagam S, Hunsberger S, Robison WG, Jr., Stiber JA, Correa R, Epstein SE, et al. (1995) Effects of chronic systemic administration of basic fibroblast growth factor on collateral development 38. in the canine heart. Circulation 91:145–153
Lazarous DF, Shou M, Scheinowitz M, Hodge E, Thirumurti V, Kitsiou AN, Stiber JA, Lobo AD, Hunsberger S, Guetta E, Epstein SE, Unger EF (1996) Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 94:1074–1082
Lazarous DF, Unger EF, Epstein SE, Stine A, Arevato JL, Quyyumi AA (1998) Effect of basic fibroblast growth factor on lower extremity blood flow in patients with intermittent claudication: preliminary results. Circulation 98:I-456
Lehrman S (1999) Virus treatment questioned after gene therapy death. Nature 401:517–518
Losordo DW, Pickering JG, Takeshita S, Leclerc G, Gal D, Weir L, Kearney M, Jekanowski J, Isner JM (1994) Use of the rabbit ear artery to serially as-sess foreign protein secretion after site-specific ar-terial gene transfer in vivo. Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression. Circulation 89:785–792
Makinen K, Laitinen M, Manninen H, Matsi P, Al-hava E, Ylä-Herttuala S (1999) Catheter-mediated VEGF gene transfer to human lower limb arteries after PTA. Circulation 100:I-770
Martins RN, Chleboun JO, Sellers P, Sleigh M, Muir J (1994) The role of PDGF-BB on the development of the collateral circulation after acute arterial occlusion. Growth Factors 10:299–306
Morishita R, Nakamura S, Hayashi S, Taniyama Y, Moriguchi A, Nagano T, Taiji M, Noguchi H, Takeshita S, Matsumoto K, Nakamura T, Higaki J, Ogihara T (1999) Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 33:1379–1384
Nabel EG, Yang ZY, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ (1993) Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 362:844–846
Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z (1999) Vascular endothelial growth factor (VEGF) and its receptors. Faseb J 13:9–22
Nikol S, Engelmann MG, Armeanu S, Pelisek J, Fuchs A, Zaehringer C, Quilici J, Mesana T, Rolland PH (1999) District-specific influence of vascular endothelial growth factor 165 (VEGF-165) on coronary and peripheral arteries resulting in arteriogenesis or angiogenesis. Circulation 100:I-489
Pu LQ, Sniderman AD, Brassard R, Lachapelle KJ, Graham AM, Lisbona R, Symes JF (1993) Enhanced revascularization of the ischemic limb by angiogenic therapy. Circulation 88:208–215
Rauh G, Gravereaux E, Pieczek A, Curry C, Schainfeld R, Isner JM (1999) Assessment of safety and efficiency of intramuscular gene therapy with VEGF-2 in patients with critical limb ischemia. Circulation 100:I-770
Rivard A, Fabre JE, Silver M, Chen D, Murohara T, Kearney M, Magner M, Asahara T, Isner JM (1999) Age-dependent impairment of angiogenesis. Circulation 99:111–120
Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, Peters K, Isner JM (1999) Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 154:355–363
Safi J, Jr., Gloe TR, Riccioni T, Kovesdi I, Capogrossi MC (1997) Gene therapy with angiogenic factors: a new potential approach to the treatment of ischemic diseases. J Mol Cell Cardiol 29:2311–2325
Schaper W (1996) Collateral vessel growth in the human heart. Role of fibroblast growth factor-2 [editorial; comment]. Circulation 94:600–601
Schaper W, Schaper J (1993) Collateral circulation: Heart, brain, kidney, limbs. Dortrecht, Netherlands: Kluwer Academic Publishers
Shyu KG, Manor O, Magner M, Yancopoulos GD, Isner JM (1998) Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 98:2081–2087
Simovic D, Ropper AH, Isner JM, Weinberg DH (1999) Improvement in ischemic limb neuropathy after VEGF gene therapy. Circulation 100:I-770 (Abstract)
Stavri GT, Hong Y, Zachary IC, Breier G, Baskerville PA, Yla Herttuala S, Risau W, Martin JF, Erusalimsky JD (1995) Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. FEBS Lett 358:311–315
Takeshita S, Pu LQ, Stein LA, Sniderman AD, Bunting S, Ferrara N, Isner JM, Symes JF (1994) Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 90:228–234
Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM (1994) Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 93:662–670
Takeshita S, Weir L, Chen D, Zheng LP, Riessen R, Bauters C, Symes JF, Ferrara N, Isner JM (1996) Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem Biophys Res Commun 227:628–635
Takeshita S, Isshiki T, Ochiasi M, Eto K, Mori H, Tanaka E, Umetani K, Sato T (1998) Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endthelial growth factor in a rat model of hindlimb ischemia. Circulation 98:1261–1263
Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T (1999) Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5:434–438
Tsurumi Y, Takeshita S, Chen D, Kearney M, Rossow ST, Passeri J, Horowitz JR, Symes JF, Isner JM (1996) Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion [see comments]. Circulation 94:3281–3290
Tuder RM, Flook BE, Voelkel NF (1995) Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 95:1798–1807
Van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, Isner JM (1998) Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 97:381–390
Waltenberger J (1997) Modulation of growth factor action: implications for the treatment of cardiovascular diseases. Circulation 96:4083–4094
Witzenbichler B, Asahara T, Murohara T, Silver M, Spyridopoulos I, Magner M, Principe N, Kearney M, Hu JS, Isner JM (1998) Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 153:381–394
Wolfe JH, Wyatt MG (1997) Critical and subcritical ischaemia. Eur J Vasc Endovasc Surg 13:578–582
Wunsch M, Sharma HS, Markert T, Bernotat Danielowski S, Schott RJ, Kremer P, Bleese N, Schaper W (1991) In situ localization of transforming growth factor beta 1 in porcine heart: enhanced expression after chronic coronary artery constriction. J Mol Cell Cardiol 23:1051–1062
Yla-Herttuala S, Martin JF (2000) Cardiovascular gene therapy. Lancet 355:213–222
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Engelmann, M.G., Nikol, S. (2002). Therapeutische Angiogenese. In: Vallbracht, C., Roth, FJ., Strauss, A.L. (eds) Interventionelle Gefäßtherapie. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57540-2_32
Download citation
DOI: https://doi.org/10.1007/978-3-642-57540-2_32
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-642-63296-9
Online ISBN: 978-3-642-57540-2
eBook Packages: Springer Book Archive